Mutations in topoisomerase I as a self-resistance mechanism coevolved with the production of the anticancer alkaloid camptothecin in plants
- 6 May 2008
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 105 (18) , 6782-6786
Abstract
Plants produce a variety of toxic compounds, which are often used as anticancer drugs. The self-resistance mechanism to these toxic metabolites in the producing plants, however, remains unclear. The plant-derived anticancer alkaloid camptothecin (CPT) induces cell death by targeting DNA topoisomerase I (Top1), the enzyme that catalyzes changes in DNA topology. We found that CPT-producing plants, including Camptotheca acuminata , Ophiorrhiza pumila , and Ophiorrhiza liukiuensis , have Top1s with point mutations that confer resistance to CPT, suggesting the effect of an endogenous toxic metabolite on the evolution of the target cellular component. Three amino acid substitutions that contribute to CPT resistance were identified: Asn421Lys, Leu530Ile, and Asn722Ser (numbered according to human Top1). The substitution at position 722 is identical to that found in CPT-resistant human cancer cells. The other mutations have not been found to date in CPT-resistant human cancer cells; this predicts the possibility of occurrence of these mutations in CPT-resistant human cancer patients in the future. Furthermore, comparative analysis of Top1s of CPT-producing and nonproducing plants suggested that the former were partially primed for CPT resistance before CPT biosynthesis evolved. Our results demonstrate the molecular mechanism of self-resistance to endogenously produced toxic compounds and the possibility of adaptive coevolution between the CPT production system and its target Top1 in the producing plants.Keywords
This publication has 31 references indexed in Scilit:
- Transport of camptothecin in hairy roots of Ophiorrhiza pumilaPhytochemistry, 2007
- How do antibiotic‐producing bacteria ensure their self‐resistance before antibiotic biosynthesis incapacitates them?Molecular Microbiology, 2007
- Positive selection driving diversification in plant secondary metabolismProceedings of the National Academy of Sciences, 2006
- Reduced expression of top1 gene induces programmed cell death and alters ascorbate metabolism in Daucus carota cultured cellsJournal of Experimental Botany, 2006
- Mechanisms of Camptothecin Resistance by Human Topoisomerase I MutationsJournal of Molecular Biology, 2004
- Disruption of a DNA Topoisomerase I Gene Affects Morphogenesis in ArabidopsisThe Plant Cell, 2002
- Substitutions of Asn-726 in the Active Site of Yeast DNA Topoisomerase I Define Novel Mechanisms of Stabilizing the Covalent Enzyme-DNA IntermediateJournal of Biological Chemistry, 2000
- Gene Mutation Analysis and Quantitation of DNA Topoisomerase I in Previously Untreated Non‐small Cell Lung CarcinomasJapanese Journal of Cancer Research, 1997
- Comparative Protein Modelling by Satisfaction of Spatial RestraintsJournal of Molecular Biology, 1993
- Cloning and Characterization of an Arabidopsis thaliana Topoisomerase I GenePlant Physiology, 1992